Quidel Corporation과 Ortho Clinical Diagnostics의 역량을 통합하여 고도로 복잡한 대량의 검체들을 처리하는 병원과 임상 진단검사실부터 현장 진료, 소매 및 처방전이 필요 없는 일반 의약품 시장에 이르기까지 전체 의료 분야에 서비스를 제공합니다. 이를 통해 QuidelOrtho는 끊임없이 변화하는 환경에서 진단의 전통을 이어가며 진단검사 과학과 치료의 발전을 위해 미지의 세계를 열정적으로 추구하고 있습니다.
미래의 약속에 대한 최초의 역사
QuidelOrtho는 설립 초기부터 진단 과학의 발전과 전 세계 사람들의 삶의 질 향상에 헌신해 왔습니다. 영상과 인터랙티브 타임라인을 통해 QuidelOrtho의 역사와 더 건강한 미래를 위한 유산을 어떻게 발전시켜 나가는지 자세히 알아보세요.
수년에 걸쳐
2020s
2025
QuidelOrtho® Results Manager™ 시스템 출시, 현대 검사실의 증가하는 요구에 부응하기 위해 진단 포트폴리오 전반의 정보 역량을 강화
2024
가정용 QuickVue® COVID-19 검사에 대한 FDA 510(k) 승인 획득
2023
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS-CoV-2 Antigen+ FIA
QuidelOrtho Receives De Novo Classification for two SARS-CoV-2 Antibody tests: VITROS® Immunodiagnostics Products Anti-SARS-CoV-2 Total Test and VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 IgG test
2022
Health Canada Grants License for Quidel® TriageTrue® High-Sensitivity Troponin l Test to Aid in the Diagnosis of Myocardial Infarction
Quidel Corporation and Ortho Clinical Diagnostics unite as QuidelOrtho with an 80-year history of innovation
2021
Quidel recieves FDA EUA for QuickVue® At-Home OTC COVID-19 Test
Ortho begins trading on Nasdaq under the symbol OCDX
2020
Quidel recieves FDA EUA for Sofia® 2 SARS Antigen FIA, the first rapid antigen test for COVID-19
Ortho launches two VITROS® SARS-CoV-2 antibody tests, receiving CE Marks and among the first FDA EUAs for high-volume COVID-19 testing; SARS-CoV-2 antigen test follows in 2021
2010s
2017
Quidel acquires Triage® cardiac and toxicology product line
2016
Ortho receives FDA clearance for Ortho Vision®
2015
Ortho receives FDA clearance for VITROS® automated solutions
2014
The Carlyle Group acquires Ortho Clinical Diagnostics from Johnson & Johnson
2013
Ortho launches Ortho® Workstation
2011
Quidel receives FDA clearance for Sofia®
2010
Quidel acquires Diagnostic Hybrids, Inc.
2000s
2003
Ortho launches Ortho ProVue®, the first fully automated immunohematology sytem for use with the ID-Micro Typing SystemTM (ID-MTS) Gel Test in North America
2000
Ortho receives first FDA approval for automated random access VITROS® ECiQ Immunodiagnostic System.
1990s
1999
Quidel receives FDA clearance for world's first rapid diagnostics flu test, QuickVue® Influenza Test A+B
1998
Ortho introduces Ortho SummitTM, the first truly automated blood and plasma screening system in the U.S.
1997
Ortho Clinical Diagnostics is formed following the 1994 Johnson & Johnson acquisition of Kodak's diagnostics business
1991
Quidel begins trading on Nasdaq under the symbol QDEL
1980s
1989
Ortho introduces the first hepatitis C antibody test
1985
Quidel receives FDA clearance for Strep A testing
1983
Quidel introduces the first commercial product for pregnancy testing
1970s
1979
Quidel Corporation is founded in San Diego, CA
1978
Kodak Clinical Diagnositics introduces patented thin-film dry slide technology
1940s
1947
Ortho develops the first blood bank anti-D test for the clinical market
1930s
1939
Ortho Products, Inc. is formed in Linden, N.J. as a divison of Johnson & Johnson
